JPMorgan Raises Price Target on Globe Life Inc. (GL) to $181 and Reiterates an Overweight Rating

On February 6, 2026, JPMorgan expert Jimmy Bhullar raised his terms people connected Globe Life Inc. (NYSE:GL) to $181 from $180 and reiterated an Overweight rating. The humble accommodation followed the company’s latest net update and the company’s fiscal 2026 net outlook.

A time earlier, connected February 5, 2026, Globe Life Inc. (NYSE:GL) reported fourth-quarter gross of $1.52 billion, somewhat beneath the statement estimation of $1.53 billion. While the apical enactment came successful somewhat little than statement expectations, capitalist absorption centered much connected the company’s guardant outlook. For fiscal twelvemonth 2026, Globe Life Inc. (NYSE:GL) reportedly sees net of $14.95 to $15.65 per share, compared with a statement estimation of $15.03. The scope suggests absorption sees country for continued net growth.

Globe Life Inc. (NYSE:GL) provides beingness and supplemental wellness security products chiefly to lower-middle- and middle-income households successful the United States. Through its subsidiaries, the institution operates crossed Life Insurance, Supplemental Health Insurance, and Investments, offering a premix of full and word beingness policies alongside Medicare supplement and limited-benefit wellness products specified arsenic accident, cancer, and captious unwellness coverage.

While we admit the imaginable of GL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and  12 Best Nuclear Energy Stocks to Buy Now

Disclosure: None.